A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

NCT00360087 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

236

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Pulmonary Hypertension
Sickle Cell Anemia

Interventions

DRUG: Bosentan

Sponsor

Actelion

Collaborators

[object Object]